• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » FDA approves Hologic sterilization treatment

FDA approves Hologic sterilization treatment

July 7, 2009 By MassDevice staff

The Food & Drug Administration gave the nod to Hologic Inc.‘s Adiana sterilization treatment, which uses a minimally invasive natural orifice surgical technique to provide permanent contraception.

The Bedford women’s health products maker said the the federal safety monitor gave pre-market approval for procedure, which involves threading an endoscope through the vagina, cervix and uterus into the fallopian tubes, where radiofrequency energy is applied to small sections of the tube.

Tony Kingsley, SVP of gynecological surgical products, told MassDevice the catheter delivers about 3 watts of energy for roughly 60 seconds in order to create a tiny, shallow lesion in the fallopian tube. A small, silicon matrix plug with a solid core is then inserted at the site to block ova from contact with sperm.

“That lesion stimulates a healing response from the body,” Kingsley said. “The reaction of the tissue of the fallopian tube is to grow into and through the pores of the matrix and thereby occlude the tube. It’s a clever and elegant technique. This is a less-than-12-minute procedure that can be done in the doctor’s office.”

The technique is fully effective after three months, as new tissue enfolds the implanted plugs. Patients continue to use birth control during that three-month period, until an X-ray confirms that the plugs are in place and working properly.

It’s an alternative to tubal ligation, in which surgeons tie off the fallopian tubes; about 700,000 women have tubal ligations each year, according to Kingsley. In clinical trials, Adiana’s efficacy rate was 98.4 percent after three years, he added (about 2 percent of tubal ligations fail).

“That’s exciting data. No sterilization method is perfect,” Kingsley said, adding that the cost of procedure itself will vary according to patients’ insurance coverage (“In an office setting, it’s conceivable the patient might have only the co-pay,” he told us).

Kingsley said the treatment should be available within a few weeks, once Hologic has a chance to run participating doctors through what he called “a pretty rigorous training requirement.”

The technique won CE Mark approval in the European Union earlier this year and has been available since about February there, he added.

Filed Under: Business/Financial News, Gynecological

More recent news

  • Citi downgrades Boston Scientific as cyberattack recovery compounds competitive pressure
  • Autonomix taps former Medtronic FDA counsel head for board of directors
  • Medtronic strengthens robotic surgery position with Cornerstone deal, analysts say
  • Science Corp. names president as it looks to roll out vision-restoring implant
  • Mindray looks to fill hospital ventilator gap left by Philips’ exit

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy